By
September 23, 2026
9 min read
Autonomous Medical Coding Requires a Build, Buy, or Augment Decision Before You Sign a Vendor



What Is Autonomous Medical Coding, and How Is It Different From CAC?
Autonomous medical coding assigns billing codes to a clinical encounter with no coder touching the chart at all, and it only routes to a human when the system's own confidence score falls below a set threshold. Computer-assisted coding (CAC), the software most health systems already own, works differently: it suggests codes and a human coder reviews and finalizes every single one. That distinction, full autonomy on high-confidence charts versus suggestion-plus-review on every chart, is the whole category shift, and it's why Gartner now tracks "Autonomous Clinical Coding" as its own market, separate from the RCM and CAC software categories it used to sit inside.
KLAS Research defines the category as software that assigns codes "with minimal or no human intervention," which is a more precise bar than most vendor marketing implies. CAC has been around since the early 2000s and its productivity gains are well documented: industry sources cite coder productivity improvements in the 25% to 45% range when coders review AI-suggested codes instead of coding from scratch. Autonomous coding is a different architecture entirely. It's built on a confidence-threshold model: charts scoring above the threshold post straight to billing, charts below it queue for a human coder, and the fraction that clears the threshold is what vendors call the "automation rate." That number, not accuracy alone, is the real health of the system, because a vendor can inflate accuracy simply by setting the threshold high enough that almost nothing clears it.
Why Health Systems Are Moving Beyond CAC Now
Three pressures are converging: a shrinking coder workforce, rising denial rates, and RCM leaders under pressure to cut cost per claim without adding headcount. Coding backlogs delay billing, and delayed billing delays cash. CAC alone hasn't solved this because a human still reviews every chart, which caps the throughput gain at whatever your coder headcount can review in a day.
Autonomous coding is attractive because it removes review time from the equation for the encounters that don't need it. A straightforward ER visit or a radiology read with a clean, well-structured note doesn't need a coder's clinical judgment applied line by line. It needs someone available for the 10% to 20% of charts that are genuinely ambiguous. That's the pitch, and it's a real one. It's also why we've seen a Reddit thread in r/MedicalCoding with 140-plus comments describing a hospital planning to replace its entire coding staff within 18 months. Take that as anecdote, not roadmap. Most health systems moving in this direction are augmenting coder capacity on specific service lines, not eliminating the function.
Where Autonomous Coding Actually Works Today (and Where It Doesn't)
Radiology, pathology, emergency medicine, and straightforward evaluation and management (E/M) visits are where autonomous coding is genuinely production-ready across multiple vendor and analyst sources. These encounter types share a common trait: structured, template-driven documentation with limited clinical ambiguity. A chest X-ray read follows a predictable format. A routine E/M visit for a known condition rarely requires interpretive judgment about what happened in the room.
Complex inpatient coding is a different problem. Multiple comorbidities, contradictory notes between specialists, and DRG assignment that depends on clinical judgment about which condition was the principal diagnosis: none of that resolves cleanly with a confidence score. Vendors selling into this space know it, which is why the credible ones (and you should treat this as a signal of credibility) talk about service-line rollout rather than hospital-wide replacement. If a vendor pitches full autonomous coverage across every specialty on day one, that's the tell that you're talking to a sales deck, not an engineering team that has actually shipped this. The AHIMA toolkit makes a related point worth sitting with: even CAC, the older and more conservative technology, still requires ongoing human oversight because natural language processing on clinical text has known failure modes around negation, ambiguous abbreviations, and template artifacts. Autonomous coding inherits all of that risk and removes the safety net of universal review.
Build, Buy, or Augment: The Real Decision Health Systems Face
Most health systems frame this as buy-or-don't-buy. That's the wrong frame. The real decision is build, buy, or augment, and the right answer depends on how standardized your documentation is and how much you're willing to expose PHI to a vendor's model.
Buy makes sense if your case mix is dominated by the specialties where autonomous coding is mature (radiology, ER, straightforward E/M) and you're comfortable with a vendor's model touching PHI under a signed BAA. This is the fastest path and the lowest engineering lift. It's also the path where you have the least control over the confidence threshold, the least visibility into why a chart cleared or didn't, and the most exposure if the vendor changes its model without telling you (more on that below).
Augment is the middle path: keep your existing CAC or EHR-native coding tools and layer a narrow, purpose-built autonomous layer on top of one or two service lines where you have clean, high-volume, low-ambiguity documentation. This is where we see the most defensible ROI, because you're not betting the whole coding operation on a black box. It's also the path most compliance officers can actually sign off on, because the blast radius of a bad decision is contained to one service line.
Build is the right call when data sensitivity, audit exposure, or documentation idiosyncrasy make a generic vendor model a poor fit, and when you want the confidence-threshold logic, the audit trail, and the routing rules to be something your compliance team designed rather than something a vendor configured for you behind an API. This is a heavier lift, typically weeks not days, but it's the only path that gives you full visibility into every routing decision and full ownership of the resulting IP instead of a subscription you're renting forever. Genta AI Solutions has built comparable document-intake and classification pipelines for medical-legal operations, including an engagement with Preferred Med Network where document intake and case assignment now run on autopilot with agents that raise exceptions only on low confidence or missing data, saving roughly $300K a year. The architecture pattern (confidence-based auto-processing with human escalation) is the same pattern autonomous coding needs; the domain specifics of coding compliance are what change.
The broader decision logic here overlaps heavily with what we've written about revenue cycle automation build versus buy, since coding is one input into a much larger RCM pipeline, and coding errors are one of the most common upstream causes of the denials covered in our denial management build-vs-buy piece.
What to Ask an Autonomous Coding Vendor Before You Sign
Ask these five questions before any contract gets signed, and get the answers in writing, not in a sales call.
How is your accuracy number calculated: against a human coder's original code, against a post-audit "gold standard" code, or against your own model's self-reported confidence?
What is your automation rate broken down by specialty and encounter type, not blended across your whole customer base?
What exactly happens to a chart that falls below the confidence threshold, who reviews it, and what's the SLA for that review?
Where does PHI go during processing, is it used to retrain your model, and can you produce a data flow diagram, not just a BAA?
How often does the underlying model change, and do you notify us before an update that could shift the confidence threshold or coding behavior on our charts?
That last question matters more than it looks. A model update that silently changes what clears the threshold is a compliance event, not a routine software patch, and most vendor contracts don't obligate them to tell you when it happens.
The Compliance and Audit Risk Nobody's Pricing In
Auto-posting a claim without human review changes your organization's audit exposure, and AHIMA's toolkit is explicit about this: CAC and autonomous systems shift how a health system is exposed to RAC (Recovery Audit Contractor) and other payer audits, because the coding decision trail looks different when a model made the call instead of a credentialed coder. If a RAC auditor asks why a specific code was assigned and your answer is "the model's confidence score exceeded the threshold," you need a documented, auditable reason behind that score, not just a vendor's assurance that their system is accurate. Liability is the harder question, and most contracts are vague about it on purpose. If an autonomous system mis-codes a claim that later triggers a payer audit or a fraud investigation, who absorbs the recoupment, and who absorbed the compliance risk of building the confidence threshold in the first place? This is precisely the kind of exposure that pushes some health systems toward self-hosted, client-owned pipelines instead of a SaaS vendor's black box: with a self-hosted model running on the health system's own infrastructure with no data retention by a third party, the audit trail and the liability sit where they should, with the entity that owns the deployment. It's also worth reading alongside our piece on what HIPAA-compliant AI actually requires beyond a signed BAA, because a BAA covers you on paper far less than most RCM leaders assume.
What ROI Actually Looks Like
Vendor-claimed numbers need independent verification before they go into a board deck. Fathom Health publishes a named customer result, Your Health, at a 95.5% automation rate and 98.3% accuracy across all service lines. Nym Health claims 95%-plus accuracy end to end without human validation. Both are credible companies and both numbers are worth taking seriously, but neither number transfers automatically to your case mix. A health system with a heavy inpatient load and inconsistent physician documentation will not hit a vendor's marketed accuracy rate, because that rate was almost certainly measured on the specialties where autonomous coding already works well. Before trusting any dashboard, run a parallel audit for 60 to 90 days: have human coders independently code a sample of the same charts the autonomous system processed, then compare. Look at accuracy by service line, not blended. Look at the automation rate under your actual documentation quality, not a demo environment's cleaned-up sample charts. The peer-reviewed literature on computer-assisted coding is consistent on one point: performance is highly sensitive to documentation quality and specialty mix, and generic benchmarks don't generalize across health systems the way vendor marketing implies.
If you're working through this decision, this is exactly what a Genta AI Solutions Discovery phase maps out before any code gets written, and we're happy to compare notes.
Frequently asked questions
What is autonomous medical coding, and how is it different from computer-assisted coding (CAC)?
CAC suggests codes for a human coder to review and finalize on every chart. Autonomous coding auto-posts codes for charts that clear a confidence threshold and only routes low-confidence or ambiguous charts to a human. The difference is architectural: one assumes universal human review, the other assumes selective review by exception.
Is AI going to replace medical coders?
Not broadly, not yet. What shifts is the job itself: less time coding routine, high-confidence charts, more time on exception handling, auditing model output, and reviewing the ambiguous cases the system routes out. Health systems moving fastest are augmenting specific service lines, not eliminating coding staff wholesale.
Which medical specialties or encounter types are actually ready for autonomous coding today?
Radiology, pathology, emergency medicine, and straightforward E/M visits are the mature use cases across multiple vendor and analyst sources, thanks to structured, template-driven documentation. Complex inpatient coding, with multiple comorbidities and judgment calls on principal diagnosis, still needs a human coder.
How can autonomous coding support or undermine compliance and audit readiness?
Done well, it creates a consistent, documented rationale for every code assigned. Done poorly, it auto-posts claims with no auditable reasoning behind the confidence score, which AHIMA flags as a direct factor in RAC and payer audit exposure. The determining factor is whether your organization, not just the vendor, can explain every coding decision on demand.
What accuracy rate should a health system actually expect, and how do you verify a vendor's claimed number?
Published vendor numbers range roughly 95% to 98%, but they're measured on the vendor's own customer base and often skew toward easier specialties. Run a 60 to 90 day parallel audit comparing the vendor's output against independent human coding on your actual chart mix before trusting any marketed figure.
Tell us where the manual work hurts
We’ll tell you straight whether AI can fix it, what it costs, and what it should return. Whatever we build, you own.
Tell us where the manual work hurts
We’ll tell you straight whether AI can fix it, what it costs, and what it should return. Whatever we build, you own.
Tell us where the manual work hurts
We’ll tell you straight whether AI can fix it, what it costs, and what it should return. Whatever we build, you own.
By
September 23, 2026
9 min read
Autonomous Medical Coding Requires a Build, Buy, or Augment Decision Before You Sign a Vendor



What Is Autonomous Medical Coding, and How Is It Different From CAC?
Autonomous medical coding assigns billing codes to a clinical encounter with no coder touching the chart at all, and it only routes to a human when the system's own confidence score falls below a set threshold. Computer-assisted coding (CAC), the software most health systems already own, works differently: it suggests codes and a human coder reviews and finalizes every single one. That distinction, full autonomy on high-confidence charts versus suggestion-plus-review on every chart, is the whole category shift, and it's why Gartner now tracks "Autonomous Clinical Coding" as its own market, separate from the RCM and CAC software categories it used to sit inside.
KLAS Research defines the category as software that assigns codes "with minimal or no human intervention," which is a more precise bar than most vendor marketing implies. CAC has been around since the early 2000s and its productivity gains are well documented: industry sources cite coder productivity improvements in the 25% to 45% range when coders review AI-suggested codes instead of coding from scratch. Autonomous coding is a different architecture entirely. It's built on a confidence-threshold model: charts scoring above the threshold post straight to billing, charts below it queue for a human coder, and the fraction that clears the threshold is what vendors call the "automation rate." That number, not accuracy alone, is the real health of the system, because a vendor can inflate accuracy simply by setting the threshold high enough that almost nothing clears it.
Why Health Systems Are Moving Beyond CAC Now
Three pressures are converging: a shrinking coder workforce, rising denial rates, and RCM leaders under pressure to cut cost per claim without adding headcount. Coding backlogs delay billing, and delayed billing delays cash. CAC alone hasn't solved this because a human still reviews every chart, which caps the throughput gain at whatever your coder headcount can review in a day.
Autonomous coding is attractive because it removes review time from the equation for the encounters that don't need it. A straightforward ER visit or a radiology read with a clean, well-structured note doesn't need a coder's clinical judgment applied line by line. It needs someone available for the 10% to 20% of charts that are genuinely ambiguous. That's the pitch, and it's a real one. It's also why we've seen a Reddit thread in r/MedicalCoding with 140-plus comments describing a hospital planning to replace its entire coding staff within 18 months. Take that as anecdote, not roadmap. Most health systems moving in this direction are augmenting coder capacity on specific service lines, not eliminating the function.
Where Autonomous Coding Actually Works Today (and Where It Doesn't)
Radiology, pathology, emergency medicine, and straightforward evaluation and management (E/M) visits are where autonomous coding is genuinely production-ready across multiple vendor and analyst sources. These encounter types share a common trait: structured, template-driven documentation with limited clinical ambiguity. A chest X-ray read follows a predictable format. A routine E/M visit for a known condition rarely requires interpretive judgment about what happened in the room.
Complex inpatient coding is a different problem. Multiple comorbidities, contradictory notes between specialists, and DRG assignment that depends on clinical judgment about which condition was the principal diagnosis: none of that resolves cleanly with a confidence score. Vendors selling into this space know it, which is why the credible ones (and you should treat this as a signal of credibility) talk about service-line rollout rather than hospital-wide replacement. If a vendor pitches full autonomous coverage across every specialty on day one, that's the tell that you're talking to a sales deck, not an engineering team that has actually shipped this. The AHIMA toolkit makes a related point worth sitting with: even CAC, the older and more conservative technology, still requires ongoing human oversight because natural language processing on clinical text has known failure modes around negation, ambiguous abbreviations, and template artifacts. Autonomous coding inherits all of that risk and removes the safety net of universal review.
Build, Buy, or Augment: The Real Decision Health Systems Face
Most health systems frame this as buy-or-don't-buy. That's the wrong frame. The real decision is build, buy, or augment, and the right answer depends on how standardized your documentation is and how much you're willing to expose PHI to a vendor's model.
Buy makes sense if your case mix is dominated by the specialties where autonomous coding is mature (radiology, ER, straightforward E/M) and you're comfortable with a vendor's model touching PHI under a signed BAA. This is the fastest path and the lowest engineering lift. It's also the path where you have the least control over the confidence threshold, the least visibility into why a chart cleared or didn't, and the most exposure if the vendor changes its model without telling you (more on that below).
Augment is the middle path: keep your existing CAC or EHR-native coding tools and layer a narrow, purpose-built autonomous layer on top of one or two service lines where you have clean, high-volume, low-ambiguity documentation. This is where we see the most defensible ROI, because you're not betting the whole coding operation on a black box. It's also the path most compliance officers can actually sign off on, because the blast radius of a bad decision is contained to one service line.
Build is the right call when data sensitivity, audit exposure, or documentation idiosyncrasy make a generic vendor model a poor fit, and when you want the confidence-threshold logic, the audit trail, and the routing rules to be something your compliance team designed rather than something a vendor configured for you behind an API. This is a heavier lift, typically weeks not days, but it's the only path that gives you full visibility into every routing decision and full ownership of the resulting IP instead of a subscription you're renting forever. Genta AI Solutions has built comparable document-intake and classification pipelines for medical-legal operations, including an engagement with Preferred Med Network where document intake and case assignment now run on autopilot with agents that raise exceptions only on low confidence or missing data, saving roughly $300K a year. The architecture pattern (confidence-based auto-processing with human escalation) is the same pattern autonomous coding needs; the domain specifics of coding compliance are what change.
The broader decision logic here overlaps heavily with what we've written about revenue cycle automation build versus buy, since coding is one input into a much larger RCM pipeline, and coding errors are one of the most common upstream causes of the denials covered in our denial management build-vs-buy piece.
What to Ask an Autonomous Coding Vendor Before You Sign
Ask these five questions before any contract gets signed, and get the answers in writing, not in a sales call.
How is your accuracy number calculated: against a human coder's original code, against a post-audit "gold standard" code, or against your own model's self-reported confidence?
What is your automation rate broken down by specialty and encounter type, not blended across your whole customer base?
What exactly happens to a chart that falls below the confidence threshold, who reviews it, and what's the SLA for that review?
Where does PHI go during processing, is it used to retrain your model, and can you produce a data flow diagram, not just a BAA?
How often does the underlying model change, and do you notify us before an update that could shift the confidence threshold or coding behavior on our charts?
That last question matters more than it looks. A model update that silently changes what clears the threshold is a compliance event, not a routine software patch, and most vendor contracts don't obligate them to tell you when it happens.
The Compliance and Audit Risk Nobody's Pricing In
Auto-posting a claim without human review changes your organization's audit exposure, and AHIMA's toolkit is explicit about this: CAC and autonomous systems shift how a health system is exposed to RAC (Recovery Audit Contractor) and other payer audits, because the coding decision trail looks different when a model made the call instead of a credentialed coder. If a RAC auditor asks why a specific code was assigned and your answer is "the model's confidence score exceeded the threshold," you need a documented, auditable reason behind that score, not just a vendor's assurance that their system is accurate. Liability is the harder question, and most contracts are vague about it on purpose. If an autonomous system mis-codes a claim that later triggers a payer audit or a fraud investigation, who absorbs the recoupment, and who absorbed the compliance risk of building the confidence threshold in the first place? This is precisely the kind of exposure that pushes some health systems toward self-hosted, client-owned pipelines instead of a SaaS vendor's black box: with a self-hosted model running on the health system's own infrastructure with no data retention by a third party, the audit trail and the liability sit where they should, with the entity that owns the deployment. It's also worth reading alongside our piece on what HIPAA-compliant AI actually requires beyond a signed BAA, because a BAA covers you on paper far less than most RCM leaders assume.
What ROI Actually Looks Like
Vendor-claimed numbers need independent verification before they go into a board deck. Fathom Health publishes a named customer result, Your Health, at a 95.5% automation rate and 98.3% accuracy across all service lines. Nym Health claims 95%-plus accuracy end to end without human validation. Both are credible companies and both numbers are worth taking seriously, but neither number transfers automatically to your case mix. A health system with a heavy inpatient load and inconsistent physician documentation will not hit a vendor's marketed accuracy rate, because that rate was almost certainly measured on the specialties where autonomous coding already works well. Before trusting any dashboard, run a parallel audit for 60 to 90 days: have human coders independently code a sample of the same charts the autonomous system processed, then compare. Look at accuracy by service line, not blended. Look at the automation rate under your actual documentation quality, not a demo environment's cleaned-up sample charts. The peer-reviewed literature on computer-assisted coding is consistent on one point: performance is highly sensitive to documentation quality and specialty mix, and generic benchmarks don't generalize across health systems the way vendor marketing implies.
If you're working through this decision, this is exactly what a Genta AI Solutions Discovery phase maps out before any code gets written, and we're happy to compare notes.
Frequently asked questions
What is autonomous medical coding, and how is it different from computer-assisted coding (CAC)?
CAC suggests codes for a human coder to review and finalize on every chart. Autonomous coding auto-posts codes for charts that clear a confidence threshold and only routes low-confidence or ambiguous charts to a human. The difference is architectural: one assumes universal human review, the other assumes selective review by exception.
Is AI going to replace medical coders?
Not broadly, not yet. What shifts is the job itself: less time coding routine, high-confidence charts, more time on exception handling, auditing model output, and reviewing the ambiguous cases the system routes out. Health systems moving fastest are augmenting specific service lines, not eliminating coding staff wholesale.
Which medical specialties or encounter types are actually ready for autonomous coding today?
Radiology, pathology, emergency medicine, and straightforward E/M visits are the mature use cases across multiple vendor and analyst sources, thanks to structured, template-driven documentation. Complex inpatient coding, with multiple comorbidities and judgment calls on principal diagnosis, still needs a human coder.
How can autonomous coding support or undermine compliance and audit readiness?
Done well, it creates a consistent, documented rationale for every code assigned. Done poorly, it auto-posts claims with no auditable reasoning behind the confidence score, which AHIMA flags as a direct factor in RAC and payer audit exposure. The determining factor is whether your organization, not just the vendor, can explain every coding decision on demand.
What accuracy rate should a health system actually expect, and how do you verify a vendor's claimed number?
Published vendor numbers range roughly 95% to 98%, but they're measured on the vendor's own customer base and often skew toward easier specialties. Run a 60 to 90 day parallel audit comparing the vendor's output against independent human coding on your actual chart mix before trusting any marketed figure.
Tell us where the manual work hurts
We’ll tell you straight whether AI can fix it, what it costs, and what it should return. Whatever we build, you own.
Tell us where the manual work hurts
We’ll tell you straight whether AI can fix it, what it costs, and what it should return. Whatever we build, you own.
Tell us where the manual work hurts
We’ll tell you straight whether AI can fix it, what it costs, and what it should return. Whatever we build, you own.
By
September 23, 2026
9 min read
Autonomous Medical Coding Requires a Build, Buy, or Augment Decision Before You Sign a Vendor



What Is Autonomous Medical Coding, and How Is It Different From CAC?
Autonomous medical coding assigns billing codes to a clinical encounter with no coder touching the chart at all, and it only routes to a human when the system's own confidence score falls below a set threshold. Computer-assisted coding (CAC), the software most health systems already own, works differently: it suggests codes and a human coder reviews and finalizes every single one. That distinction, full autonomy on high-confidence charts versus suggestion-plus-review on every chart, is the whole category shift, and it's why Gartner now tracks "Autonomous Clinical Coding" as its own market, separate from the RCM and CAC software categories it used to sit inside.
KLAS Research defines the category as software that assigns codes "with minimal or no human intervention," which is a more precise bar than most vendor marketing implies. CAC has been around since the early 2000s and its productivity gains are well documented: industry sources cite coder productivity improvements in the 25% to 45% range when coders review AI-suggested codes instead of coding from scratch. Autonomous coding is a different architecture entirely. It's built on a confidence-threshold model: charts scoring above the threshold post straight to billing, charts below it queue for a human coder, and the fraction that clears the threshold is what vendors call the "automation rate." That number, not accuracy alone, is the real health of the system, because a vendor can inflate accuracy simply by setting the threshold high enough that almost nothing clears it.
Why Health Systems Are Moving Beyond CAC Now
Three pressures are converging: a shrinking coder workforce, rising denial rates, and RCM leaders under pressure to cut cost per claim without adding headcount. Coding backlogs delay billing, and delayed billing delays cash. CAC alone hasn't solved this because a human still reviews every chart, which caps the throughput gain at whatever your coder headcount can review in a day.
Autonomous coding is attractive because it removes review time from the equation for the encounters that don't need it. A straightforward ER visit or a radiology read with a clean, well-structured note doesn't need a coder's clinical judgment applied line by line. It needs someone available for the 10% to 20% of charts that are genuinely ambiguous. That's the pitch, and it's a real one. It's also why we've seen a Reddit thread in r/MedicalCoding with 140-plus comments describing a hospital planning to replace its entire coding staff within 18 months. Take that as anecdote, not roadmap. Most health systems moving in this direction are augmenting coder capacity on specific service lines, not eliminating the function.
Where Autonomous Coding Actually Works Today (and Where It Doesn't)
Radiology, pathology, emergency medicine, and straightforward evaluation and management (E/M) visits are where autonomous coding is genuinely production-ready across multiple vendor and analyst sources. These encounter types share a common trait: structured, template-driven documentation with limited clinical ambiguity. A chest X-ray read follows a predictable format. A routine E/M visit for a known condition rarely requires interpretive judgment about what happened in the room.
Complex inpatient coding is a different problem. Multiple comorbidities, contradictory notes between specialists, and DRG assignment that depends on clinical judgment about which condition was the principal diagnosis: none of that resolves cleanly with a confidence score. Vendors selling into this space know it, which is why the credible ones (and you should treat this as a signal of credibility) talk about service-line rollout rather than hospital-wide replacement. If a vendor pitches full autonomous coverage across every specialty on day one, that's the tell that you're talking to a sales deck, not an engineering team that has actually shipped this. The AHIMA toolkit makes a related point worth sitting with: even CAC, the older and more conservative technology, still requires ongoing human oversight because natural language processing on clinical text has known failure modes around negation, ambiguous abbreviations, and template artifacts. Autonomous coding inherits all of that risk and removes the safety net of universal review.
Build, Buy, or Augment: The Real Decision Health Systems Face
Most health systems frame this as buy-or-don't-buy. That's the wrong frame. The real decision is build, buy, or augment, and the right answer depends on how standardized your documentation is and how much you're willing to expose PHI to a vendor's model.
Buy makes sense if your case mix is dominated by the specialties where autonomous coding is mature (radiology, ER, straightforward E/M) and you're comfortable with a vendor's model touching PHI under a signed BAA. This is the fastest path and the lowest engineering lift. It's also the path where you have the least control over the confidence threshold, the least visibility into why a chart cleared or didn't, and the most exposure if the vendor changes its model without telling you (more on that below).
Augment is the middle path: keep your existing CAC or EHR-native coding tools and layer a narrow, purpose-built autonomous layer on top of one or two service lines where you have clean, high-volume, low-ambiguity documentation. This is where we see the most defensible ROI, because you're not betting the whole coding operation on a black box. It's also the path most compliance officers can actually sign off on, because the blast radius of a bad decision is contained to one service line.
Build is the right call when data sensitivity, audit exposure, or documentation idiosyncrasy make a generic vendor model a poor fit, and when you want the confidence-threshold logic, the audit trail, and the routing rules to be something your compliance team designed rather than something a vendor configured for you behind an API. This is a heavier lift, typically weeks not days, but it's the only path that gives you full visibility into every routing decision and full ownership of the resulting IP instead of a subscription you're renting forever. Genta AI Solutions has built comparable document-intake and classification pipelines for medical-legal operations, including an engagement with Preferred Med Network where document intake and case assignment now run on autopilot with agents that raise exceptions only on low confidence or missing data, saving roughly $300K a year. The architecture pattern (confidence-based auto-processing with human escalation) is the same pattern autonomous coding needs; the domain specifics of coding compliance are what change.
The broader decision logic here overlaps heavily with what we've written about revenue cycle automation build versus buy, since coding is one input into a much larger RCM pipeline, and coding errors are one of the most common upstream causes of the denials covered in our denial management build-vs-buy piece.
What to Ask an Autonomous Coding Vendor Before You Sign
Ask these five questions before any contract gets signed, and get the answers in writing, not in a sales call.
How is your accuracy number calculated: against a human coder's original code, against a post-audit "gold standard" code, or against your own model's self-reported confidence?
What is your automation rate broken down by specialty and encounter type, not blended across your whole customer base?
What exactly happens to a chart that falls below the confidence threshold, who reviews it, and what's the SLA for that review?
Where does PHI go during processing, is it used to retrain your model, and can you produce a data flow diagram, not just a BAA?
How often does the underlying model change, and do you notify us before an update that could shift the confidence threshold or coding behavior on our charts?
That last question matters more than it looks. A model update that silently changes what clears the threshold is a compliance event, not a routine software patch, and most vendor contracts don't obligate them to tell you when it happens.
The Compliance and Audit Risk Nobody's Pricing In
Auto-posting a claim without human review changes your organization's audit exposure, and AHIMA's toolkit is explicit about this: CAC and autonomous systems shift how a health system is exposed to RAC (Recovery Audit Contractor) and other payer audits, because the coding decision trail looks different when a model made the call instead of a credentialed coder. If a RAC auditor asks why a specific code was assigned and your answer is "the model's confidence score exceeded the threshold," you need a documented, auditable reason behind that score, not just a vendor's assurance that their system is accurate. Liability is the harder question, and most contracts are vague about it on purpose. If an autonomous system mis-codes a claim that later triggers a payer audit or a fraud investigation, who absorbs the recoupment, and who absorbed the compliance risk of building the confidence threshold in the first place? This is precisely the kind of exposure that pushes some health systems toward self-hosted, client-owned pipelines instead of a SaaS vendor's black box: with a self-hosted model running on the health system's own infrastructure with no data retention by a third party, the audit trail and the liability sit where they should, with the entity that owns the deployment. It's also worth reading alongside our piece on what HIPAA-compliant AI actually requires beyond a signed BAA, because a BAA covers you on paper far less than most RCM leaders assume.
What ROI Actually Looks Like
Vendor-claimed numbers need independent verification before they go into a board deck. Fathom Health publishes a named customer result, Your Health, at a 95.5% automation rate and 98.3% accuracy across all service lines. Nym Health claims 95%-plus accuracy end to end without human validation. Both are credible companies and both numbers are worth taking seriously, but neither number transfers automatically to your case mix. A health system with a heavy inpatient load and inconsistent physician documentation will not hit a vendor's marketed accuracy rate, because that rate was almost certainly measured on the specialties where autonomous coding already works well. Before trusting any dashboard, run a parallel audit for 60 to 90 days: have human coders independently code a sample of the same charts the autonomous system processed, then compare. Look at accuracy by service line, not blended. Look at the automation rate under your actual documentation quality, not a demo environment's cleaned-up sample charts. The peer-reviewed literature on computer-assisted coding is consistent on one point: performance is highly sensitive to documentation quality and specialty mix, and generic benchmarks don't generalize across health systems the way vendor marketing implies.
If you're working through this decision, this is exactly what a Genta AI Solutions Discovery phase maps out before any code gets written, and we're happy to compare notes.
Frequently asked questions
What is autonomous medical coding, and how is it different from computer-assisted coding (CAC)?
CAC suggests codes for a human coder to review and finalize on every chart. Autonomous coding auto-posts codes for charts that clear a confidence threshold and only routes low-confidence or ambiguous charts to a human. The difference is architectural: one assumes universal human review, the other assumes selective review by exception.
Is AI going to replace medical coders?
Not broadly, not yet. What shifts is the job itself: less time coding routine, high-confidence charts, more time on exception handling, auditing model output, and reviewing the ambiguous cases the system routes out. Health systems moving fastest are augmenting specific service lines, not eliminating coding staff wholesale.
Which medical specialties or encounter types are actually ready for autonomous coding today?
Radiology, pathology, emergency medicine, and straightforward E/M visits are the mature use cases across multiple vendor and analyst sources, thanks to structured, template-driven documentation. Complex inpatient coding, with multiple comorbidities and judgment calls on principal diagnosis, still needs a human coder.
How can autonomous coding support or undermine compliance and audit readiness?
Done well, it creates a consistent, documented rationale for every code assigned. Done poorly, it auto-posts claims with no auditable reasoning behind the confidence score, which AHIMA flags as a direct factor in RAC and payer audit exposure. The determining factor is whether your organization, not just the vendor, can explain every coding decision on demand.
What accuracy rate should a health system actually expect, and how do you verify a vendor's claimed number?
Published vendor numbers range roughly 95% to 98%, but they're measured on the vendor's own customer base and often skew toward easier specialties. Run a 60 to 90 day parallel audit comparing the vendor's output against independent human coding on your actual chart mix before trusting any marketed figure.
Tell us where the manual work hurts
We’ll tell you straight whether AI can fix it, what it costs, and what it should return. Whatever we build, you own.
Tell us where the manual work hurts
We’ll tell you straight whether AI can fix it, what it costs, and what it should return. Whatever we build, you own.
Tell us where the manual work hurts
We’ll tell you straight whether AI can fix it, what it costs, and what it should return. Whatever we build, you own.